Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS
· Delayed Price · Currency is USD
0.0390
-0.0084 (-17.72%)
At close: May 23, 2025
Petros Pharmaceuticals Company Description
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies.
The company is based in New York, New York.
Petros Pharmaceuticals, Inc.
Country | United States |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 18 |
CEO | Fady Boctor |
Contact Details
Address: 1185 Avenue of the Americas New York, Delaware 10036 United States | |
Phone | 973 242 0005 |
Website | petrospharma.com |
Stock Details
Ticker Symbol | PTPI |
Exchange | OTCMKTS |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
ISIN Number | US71678J1007 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Fady Boctor M.B.A. | President and Chief Commercial Officer |
Mitchell S. Arnold M.B.A. | Vice President of Finance and Chief Accounting Officer |